Cases & Deals

  • Home
  • Practices
  • Sanofi sells Dermacyd and Lactacyd brands to EMS S.A.

Share

Sanofi sells Dermacyd and Lactacyd brands to EMS S.A.

May 2023

Client(s) Sanofi

Jones Day is advising Sanofi in the sale of 11 Dermacyd line products in Brazil and 13 Lactacyd line products in Mexico, Peru, and Argentina to EMS S.A. The transaction is expected to close in the first quarter of 2024, subject to approval of relevant regulatory authorities and other customary closing conditions.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.